Enovix Co. (NASDAQ:ENVX – Free Report) – Investment analysts at Northland Capmk issued their FY2026 earnings per share (EPS) estimates for shares of Enovix in a note issued to investors on Friday, November 22nd. Northland Capmk analyst G. Richard expects that the company will post earnings of ($0.65) per share for the year. The consensus estimate for Enovix’s current full-year earnings is ($1.17) per share.
A number of other analysts also recently commented on the stock. Craig Hallum boosted their price objective on shares of Enovix from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Oppenheimer reaffirmed an “outperform” rating and issued a $36.00 price objective on shares of Enovix in a research note on Monday, August 26th. Benchmark reaffirmed a “buy” rating and set a $25.00 price objective on shares of Enovix in a report on Wednesday, October 30th. Canaccord Genuity Group upped their target price on Enovix from $17.00 to $20.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $20.50.
Enovix Price Performance
Enovix stock opened at $9.53 on Monday. The business has a 50 day simple moving average of $10.00 and a 200-day simple moving average of $11.31. Enovix has a 12 month low of $5.70 and a 12 month high of $18.68. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The stock has a market capitalization of $1.70 billion, a PE ratio of -5.92 and a beta of 1.99.
Enovix (NASDAQ:ENVX – Get Free Report) last issued its earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.03. The business had revenue of $4.30 million during the quarter, compared to analysts’ expectations of $4.11 million. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. During the same quarter in the prior year, the business posted ($0.27) EPS.
Insider Transactions at Enovix
In other Enovix news, insider Arthi Chakravarthy sold 35,000 shares of Enovix stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $13.00, for a total value of $455,000.00. Following the transaction, the insider now owns 343,305 shares in the company, valued at approximately $4,462,965. The trade was a 9.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 15.70% of the company’s stock.
Hedge Funds Weigh In On Enovix
Several institutional investors and hedge funds have recently added to or reduced their stakes in ENVX. Prospera Private Wealth LLC acquired a new stake in shares of Enovix during the third quarter worth approximately $27,000. Blue Trust Inc. raised its holdings in Enovix by 102.1% in the 2nd quarter. Blue Trust Inc. now owns 1,894 shares of the company’s stock worth $29,000 after acquiring an additional 957 shares during the period. Beacon Capital Management LLC lifted its position in shares of Enovix by 71.9% during the 1st quarter. Beacon Capital Management LLC now owns 4,298 shares of the company’s stock worth $34,000 after purchasing an additional 1,798 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Enovix by 11,176.2% during the second quarter. GAMMA Investing LLC now owns 2,368 shares of the company’s stock worth $37,000 after buying an additional 2,347 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in Enovix in the 2nd quarter worth $39,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.
About Enovix
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Recommended Stories
- Five stocks we like better than Enovix
- Compound Interest and Why It Matters When Investing
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Learn Technical Analysis Skills to Master the Stock Market
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.